Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial

Abstract Background Either benznidazole (BZN) or nifurtimox (NFX) is recommended as equivalent to treat Trypanosoma cruzi infection. Nonetheless, supportive data from randomised trials is limited to individuals treated with BZN in southern cone countries of Latin America. Methods The goal of this ra...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Juan Carlos Villar, Víctor Mauricio Herrera, Juan Guillermo Pérez Carreño, Eliana Váquiro Herrera, Yeny Zulay Castellanos Domínguez, Skarlet Marcell Vásquez, Zulma Milena Cucunubá, Nilda Graciela Prado, Yolanda Hernández
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMC 2019-07-01
Serie:	Trials
Ämnen:	Nifurtimox Benznidazole Trypanosoma cruzi Chagas disese Randomized controlled trial
Länkar:	http://link.springer.com/article/10.1186/s13063-019-3423-3
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!